Intersect Diagnostics is the only life science research and development laboratory to focus exclusively on developing proprietary assays using state-of-the-art, high-parameter spatial discovery technologies and sophisticated data analytics to advance biomarker discovery for precision therapeutics.
At Intersect Diagnostics, our core mission is to discover novel biomarker signatures for precision therapeutics.
Customer service is at the heart of everything we strive to achieve.
As a young, agile company we deliver white-glove service for our biotech and biopharma partners by designing and validating customized, bespoke assays that incorporate both well-known and novel, relatively understudied biomarkers.
We then deploy these assays in our own, Good Clinical Practice (GCP)-compliant laboratory operating under a robust Quality Management program designed to pass rigorous audits and inspections.
Our company is led by professionals with the scientific, technical, and industry knowledge needed to define and execute our core mission.
As a translational research and development laboratory focused on precision biomarkers, Intersect Diagnostics recognizes that the future of biomarker signature discovery will depend on multi-omics capabilities. Our name “Intersect” is meant to reflect that, as a company, we will position our capabilities at the continually evolving junction of emerging science and technologies. “Diagnostics” – derived from the Ancient Greek word for “discerning” or “identifying” – speaks to our core mission of discovery to advance development of therapies that will improve the lives of countless patients around the world.
Our logo design reflects our multi-omics vision by incorporating an image of an antibody’s heavy and light chains to represent our efforts in proteomic assay development, while the double helix signals the same for genomics.
Meet Our Team
IntersectDx has assembled a world-class team of executives and advisors to help manage and guide the company into the future.
